Developing the Artificial Intelligence Method and System for “Multiple Diseases Holistic Differentiation” in Traditional Chinese Medicine and Its Interpretability to Clinical Decision

IF 3.6 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Zhe Chen, Dong Zhang, Pengfei Nie, Guanhao Fan, Zhiyuan He, Hui Wang, Chenyue Zhang, Fengwen Yang, Chunxiang Liu, Junhua Zhang
{"title":"Developing the Artificial Intelligence Method and System for “Multiple Diseases Holistic Differentiation” in Traditional Chinese Medicine and Its Interpretability to Clinical Decision","authors":"Zhe Chen,&nbsp;Dong Zhang,&nbsp;Pengfei Nie,&nbsp;Guanhao Fan,&nbsp;Zhiyuan He,&nbsp;Hui Wang,&nbsp;Chenyue Zhang,&nbsp;Fengwen Yang,&nbsp;Chunxiang Liu,&nbsp;Junhua Zhang","doi":"10.1111/jebm.70016","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Aim</h3>\n \n <p>The development of artificial intelligence (AI) for traditional Chinese medicine (TCM) has played an important role in clinical decision-making, mainly reflected in the intersectionality and variability of symptoms, syndromes, and patterns for TCM multiple diseases holistic differentiation (MDHD). This study aimed to develop a TCM AI method and system for clinical decisions more transparent with explainable structural framework.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>This study developed the TCM syndrome elements integration with priori rule and deep learning (TCM-SEI-RD) method and TCM-MDHD system by high-quality expert knowledge datasets, to predict various TCM syndromes and patterns in hierarchical modules. TCM-BERT-CNN model fused the BERT with CNN model capture feature-related sequence, as the benchmark model in the TCM-SEI-RD method, to improve the performance of predicting TCM syndrome elements. The framework of the TCM-MDHD system involved the TCM-SEI-RD method and TCM “diseases—syndromes—patterns” benchmark sequences, to provide distributed results with credibility.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>For predicting results to the overall TCM syndrome elements, the TCM-SEI-RD achieves 95.4%, 94.43%, and 94.89% in precision, recall, and <i>F</i>1 score, respectively, and 3.33%, 2.28%, and 2.81% improvement over the benchmark model. TCM-MDHD system demonstrates credibility grading at each stage in various diseases and uses the practical example to illustrate the process of distributed decision-making results and transparency with credibility.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Our method and system, as the general AI technologies for TCM syndromes and patterns diagnosis in multiple diseases, can provide the clinical diagnostic basis with the best performance for the TCM preparations rational use, and distribute interpretability to the clinical decision-making process.</p>\n </section>\n </div>","PeriodicalId":16090,"journal":{"name":"Journal of Evidence‐Based Medicine","volume":"18 2","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Evidence‐Based Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jebm.70016","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Aim

The development of artificial intelligence (AI) for traditional Chinese medicine (TCM) has played an important role in clinical decision-making, mainly reflected in the intersectionality and variability of symptoms, syndromes, and patterns for TCM multiple diseases holistic differentiation (MDHD). This study aimed to develop a TCM AI method and system for clinical decisions more transparent with explainable structural framework.

Methods

This study developed the TCM syndrome elements integration with priori rule and deep learning (TCM-SEI-RD) method and TCM-MDHD system by high-quality expert knowledge datasets, to predict various TCM syndromes and patterns in hierarchical modules. TCM-BERT-CNN model fused the BERT with CNN model capture feature-related sequence, as the benchmark model in the TCM-SEI-RD method, to improve the performance of predicting TCM syndrome elements. The framework of the TCM-MDHD system involved the TCM-SEI-RD method and TCM “diseases—syndromes—patterns” benchmark sequences, to provide distributed results with credibility.

Results

For predicting results to the overall TCM syndrome elements, the TCM-SEI-RD achieves 95.4%, 94.43%, and 94.89% in precision, recall, and F1 score, respectively, and 3.33%, 2.28%, and 2.81% improvement over the benchmark model. TCM-MDHD system demonstrates credibility grading at each stage in various diseases and uses the practical example to illustrate the process of distributed decision-making results and transparency with credibility.

Conclusions

Our method and system, as the general AI technologies for TCM syndromes and patterns diagnosis in multiple diseases, can provide the clinical diagnostic basis with the best performance for the TCM preparations rational use, and distribute interpretability to the clinical decision-making process.

中医“多病整体辨证”人工智能方法和系统的开发及其对临床决策的可解释性
目的人工智能(AI)在中医临床决策中发挥了重要作用,主要体现在中医多病整体辨证(MDHD)的症状、证候和模式的交叉性和变异性上。本研究旨在开发一种更透明、结构框架可解释的中医人工智能临床决策方法和系统。方法利用高质量的专家知识数据集,开发基于先验规则和深度学习的中医证候要素集成(TCM- sei - rd)方法和TCM- mdhd系统,在层次模块中预测各种中医证候和模式。TCM-BERT-CNN模型融合了BERT和CNN模型捕获特征相关序列,作为TCM- sei - rd方法中的基准模型,提高了中医证候要素预测的性能。TCM- mdhd系统的框架包括TCM- sei - rd方法和中医“病-证-型”基准序列,以提供具有可信度的分布式结果。结果对于整体中医证候要素的预测结果,TCM- sei - rd的准确率、召回率和F1评分分别达到95.4%、94.43%和94.89%,比基准模型分别提高3.33%、2.28%和2.81%。TCM-MDHD系统对各种疾病的各个阶段进行可信度分级,并通过实例说明决策结果的分布式过程和具有可信度的透明度。结论我们的方法和系统作为多病中医证型诊断的通用人工智能技术,可为中药制剂的合理使用提供性能最佳的临床诊断依据,并具有可解释性,可用于临床决策过程。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Evidence‐Based Medicine
Journal of Evidence‐Based Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
11.20
自引率
1.40%
发文量
42
期刊介绍: The Journal of Evidence-Based Medicine (EMB) is an esteemed international healthcare and medical decision-making journal, dedicated to publishing groundbreaking research outcomes in evidence-based decision-making, research, practice, and education. Serving as the official English-language journal of the Cochrane China Centre and West China Hospital of Sichuan University, we eagerly welcome editorials, commentaries, and systematic reviews encompassing various topics such as clinical trials, policy, drug and patient safety, education, and knowledge translation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信